Eli Lilly and Company (TSX:LLY)
48.29
-0.38 (-0.78%)
Nov 6, 2026, 4:00 PM EST
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $24.40B USD in the quarter ending September 30, 2026, with 38.61% growth. This brings the company's total for the last twelve months to $86.46B, up 45.51% year-over-year. In the year 2025, Eli Lilly and Company had annual revenue of $65.18B with 44.70% growth.
Revenue (ttm)
$86.46B
Revenue Growth
+45.51%
P/S Ratio
13.85
Revenue / Employee
$1.73M
Employees
50,000
Market Cap
1.70T CAD
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Eli Lilly and Company breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 65.18B | 20.14B | 44.70% |
| Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
| Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
| Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
| Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
| Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
| Dec 31, 2019 | 22.32B | 826.20M | 3.84% |
| Dec 31, 2018 | 21.49B | -1.38B | -6.03% |
| Dec 31, 2017 | 22.87B | 1.65B | 7.77% |
| Dec 31, 2016 | 21.22B | 1.26B | 6.33% |
| Dec 31, 2015 | 19.96B | 343.10M | 1.75% |
| Dec 31, 2014 | 19.62B | -3.50B | -15.13% |
| Dec 31, 2013 | 23.11B | 509.70M | 2.25% |
| Dec 31, 2012 | 22.60B | -1.68B | -6.93% |
| Dec 31, 2011 | 24.29B | 1.21B | 5.25% |
| Dec 31, 2010 | 23.08B | 1.24B | 5.68% |
| Dec 31, 2009 | 21.84B | 1.46B | 7.19% |
| Dec 31, 2008 | 20.37B | 1.74B | 9.33% |
| Dec 31, 2007 | 18.63B | 2.94B | 18.75% |
| Dec 31, 2006 | 15.69B | 1.05B | 7.14% |
| Dec 31, 2005 | 14.65B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apotex Health | 3.20B |
| Extendicare | 2.17B |
| Curaleaf Holdings | 1.92B |
| Green Thumb Industries | 1.76B |
| WELL Health Technologies | 1.52B |
| Verano Holdings | 1.20B |
| Sienna Senior Living | 1.08B |
| Knight Therapeutics | 563.45M |
Eli Lilly and Company News
- 55 minutes ago - Eli Lilly price target raised to $1,700 from $1,610 at Jefferies - TheFly
- 2 hours ago - Novartis drops heart drug after it failed to prevent heart attacks - Stock Analysis
- 2 days ago - Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying. - Market Watch
- 2 days ago - Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly Agreement - Barrons
- 3 days ago - Healthcare Stocks Fall as Market Rout Spreads - WSJ
- 3 days ago - Hims & Hers and Eli Lilly announce agreement to expand acces to Zepbound - TheFly
- 3 days ago - Eli Lilly, Hims & Hers enter pact to expand access to Zepbound and Foundayo - TheFly
- 3 days ago - Lilly and Hims & Hers expand access to FDA-approved Lilly medicines - Business Wire